Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Leef BrandsLEEEF -4.20%29 Revenue per Share is $0.15 as of Jun. 2026. GuruFocus rates LEEEF with a GF Score™ of 29/100 and a GF Value™ of $0.11 (Significantly Overvalued). The stock has 8 warning signs investors should review. Among 902 Drug Manufacturers companies, Leef Brands ranks worse than 90.35% on this metric.
Leef Brands's revenue per share for the
three
months ended in Jun. 2026 was $0.03.
Leef Brands's revenue per share for the trailing twelve months (TTM) ended in Jun. 2026 was $0.15.
Warning Sign:
Leef Brands Inc revenue per share has been in decline for the last 5 years.
During the past 12 months, the average Revenue Per Share Growth Rate of Leef Brands was -11.70% per year.
During the past 3 years, the average Revenue Per Share Growth Rate was -19.60% per year.
During the past 5 years, the average Revenue Per Share Growth Rate was -10.90% per year.
Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get other companies' revenue growth rate.
The historical rank and industry rank for Leef Brands's Revenue per Share or its related term are showing as below:
LEEEF'
s 3-Year Revenue Growth Rate Range Over the Past 10 Years
Min: -19.6 Med: -9.4 Max: 179.3
Current: -19.6
During the past 13 years, Leef Brands's highest 3-Year average Revenue Per Share Growth Rate was 179.30% per year. The lowest was -19.60% per year. And the median was -9.40% per year.
LEEEF's 3-Year Revenue Growth Rate is ranked worse than 90.35% of 902
companies
in the Drug Manufacturers industry
Industry Median: 3.8
vs LEEEF: -19.60
His favorite companies are stalwart, those growing between 10-20% a year.
Companies in cyclical industries may see their revenue fluctuate wildly in good years and bad years.
Be Aware
Revenue can be manipulated by changing the way how revenue is booked. Companies may book sales before the payment is received, or before the revenue is fully earned. These will be added to balance sheet items such as account payable or account receivables.
Leef Brands Revenue per Share Related Terms
Leef Brands Revenue per Share Historical Data
* Premium members only.
The historical data trend for Leef Brands's Revenue per Share can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, Leef Brands's PS Ratio, along with its competitors' market caps and PS Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Leef Brands PS Ratio vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Leef Brands's PS Ratio distribution charts can be found below:
* The bar in red indicates where Leef Brands's PS Ratio falls into.
Revenue per Share is the amount of Revenue per outstanding share of the company's stock.
Also referred as sales, revenue is income that a company receives from its normal business activities, usually from the sale of goods and services to customers. Revenue is often referred to as the "top line" due to its position on the income statement at the very top.
Leef Brands's Revenue Per Share for the fiscal year that ended in Dec. 2025 is calculated as
Revenue per Share for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was $0.15
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Leef Brands (LEEEF) has a Revenue per Share of $0.15 as of Jun. 2026. Revenue per share equals the per-share value of a company's sales. View historical data on Leef Brands and its competitors. According to the industry distribution chart, Leef Brands ranks #815 out of 902 companies in the Drug Manufacturers industry, placing it in the top 90.4%.
Is Leef Brands' Revenue per Share too high?
Leef Brands' current Revenue per Share is $0.15. The Drug Manufacturers industry median Revenue per Share is 3.80. Leef Brands' value of $0.15 is 96.1% below this industry median. Based on the distribution chart, Leef Brands ranks #815 out of 902 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Leef Brands has a GF Score™ of 29/100 and is considered Significantly Overvalued, reflecting its overall financial health beyond just this single metric.
How does Leef Brands' Revenue per Share compare to ZTS?
According to the Drug Manufacturers industry distribution chart, Leef Brands ranks #815 out of 902 companies for Revenue per Share. This places Leef Brands in the lower half of its industry. The industry median Revenue per Share is 3.80. Leef Brands' value of $0.15 is 96.1% below this benchmark. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Revenue per Share for a Drug Manufacturers company?
The median Revenue per Share among Drug Manufacturers companies is 3.80, based on 902 companies in the industry. Companies in the top quartile (top 25%) have a Revenue per Share significantly above this median, while those in the bottom quartile fall well below. However, Revenue per Share should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Leef Brands's current Revenue per Share of $0.15 is 96.1% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Revenue per Share mean?
A high Revenue per Share can signal that a stock is expensive relative to its fundamentals. Revenue per share equals the per-share value of a company's sales. View historical data on Leef Brands and its competitors. For the Drug Manufacturers industry, the median Revenue per Share is 3.80 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Leef Brands's current Revenue per Share is $0.15. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Leef Brands stock overvalued right now?
Based on GuruFocus' analysis, Leef Brands (LEEEF) is currently considered Significantly Overvalued. The stock's GF Value™ is $0.11, compared to a current price of $0.21 — trading 90.9% above its estimated fair value. The current Revenue per Share is $0.15 and 96.1% below the Drug Manufacturers industry median of 3.80. Leef Brands' overall GF Score™ is 29/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Revenue per Share calculated?
Revenue per Share is calculated from a company's financial statements. For Leef Brands (LEEEF), the current Revenue per Share is $0.15 as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Leef Brands (LEEEF) Overvalued in 2026?
Based on GuruFocus' analysis, Leef Brands stock appears to be overvalued.
The current stock price of $0.21 is trading 90.9% above its estimated GF Value™ of $0.11.
GuruFocus considers Leef Brands to be Significantly Overvalued.
Key valuation signals for LEEEF:
Revenue per Share: $0.15
GF Value™: $0.11 vs. price of $0.21 (90.9% above fair value)
Industry Position: 96.1% below the Drug Manufacturers median (#815 of 902)
No single metric tells the full story. See the LEEEF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Leef Brands Inc is a vertically integrated cannabis extraction and manufacturing operator based in California. The company operates in two reportable segments: Wholesale concentrates and Retail. The wholesale concentrate segment includes the propagation, nursery, flowering canopy, drying, processing, manufacturing and distribution of cannabis concentrates. The retail segment includes company owned and operated retail cannabis store in the state of California. It derives majority of the revenue from Wholesale concentrates segment.
29GF Score
Get the complete analysis for LEEEF
Revenue per Share is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
LEEEF has been successfully added to your 
